When: Close below $354 on heavy volume

Then: Trim to Underweight, reassess at $338-340 lower Bollinger

When: $360-380 range with chop

Then: Maintain Hold, no position change

HOLD: maintain benchmark-weight exposure, do not add fresh capital until September 2 catalyst resolves, set stop at 354, cap position size at benchmark weight, reassess post-print with new information.

• Trailing P/E is 61x earnings, not a deep value setup; stock is priced for perfection with the market clearly signaling doubt via the 200 SMA defense
• 0.4 PEG ratio is backward-looking and ignores execution risk, valuation compression risk, and regime shifts
• 200 SMA at 368.53 is defended by only 26 cents, a level breakable on a single bad session
• Technical signals are bearish: MACD widening bearish, RSI failed its bounce, rally-day volume below average
• Pro-forma net debt to EBITDA expands from 1.07x to approximately 3.0-3.1x from the AI debt-financing deal, creating meaningful leverage in a name that had been deleveraging
• AI deal structure resembles project finance rather than traditional semis, risking unfavorable rating agency treatment and refinancing risk in higher-for-longer rate environment
• Downside risk is 15-20 percent on confirmed 200 SMA break (path to 338, then 300), not the 2 points framed by aggressive case
• Stop loss at 354 only protects against single-session gap, not multi-day unwind below the stop
• Google TPU displacement represents existential structural risk to revenue base, not merely a narrative
• 30-quarter beat streak is survivorship bias; beat odds and magnitude relative to forward guidance are what matter
• AVGO experienced a 25 percent drawdown in two months during August, demonstrating realized volatility rather than coiled spring potential
• Anthropic dependency adds counterparty risk not captured in trailing multiples

→ vs aggressive: The 0.4 PEG ratio ignores a 61x trailing P/E, execution risk, and valuation compression risk; it is selection bias to focus solely on forward growth metrics

→ vs aggressive: The 200 SMA defense of 26 cents is not a strong floor but a fragile level; ATR compression, bearish MACD, failed RSI bounce, and below-average volume on rallies contradict the coiled spring framing

→ vs aggressive: The AI debt deal moves net debt to EBITDA to 3.0-3.1x; this is project finance-like leverage with refinancing risk that the market has not fully priced, representing asymmetric downside

→ vs aggressive: The risk-reward framing of 2 points downside is misleading; on a September 2 disappointment, the stock can resume August's 25 percent two-month decline toward 338-300, a 15-20 percent move, not 2 points

→ vs aggressive: Deeply negative sentiment does not guarantee violent upside; semiconductor names see bars reset higher each quarter, and outsized beat reactions are not historically consistent

→ vs aggressive: Google TPU in-house silicon development is an existential structural risk to revenue, not a narrative Broadcom can simply address and overcome

→ vs aggressive: Assuming Tan's historical deleveraging behavior continues into this AI financing structure is extrapolation, not analysis; rating agencies may not apply traditional chip vendor credit treatment

HOLD at benchmark weight; post-catalyst re-engagement framework: add to overweight if 386 reclaimed with volume (target 420-428), trim to underweight if 354 breaks on heavy volume, otherwise hold at benchmark in 360-380 range

• ATR compression from 19.25 to 13.96 signals volatility incoming but NOT direction; neutral analyst calls this 'narrative bias' from aggressive camp
• 200 SMA at 368.53 defended by 26 cents is not a strong base and can crack on single bad session in high-beta name
• Pro-forma net debt to EBITDA expansion from 1.07x to approximately 3.0 to 3.1x puts Broadcom at upper edge of investment grade
• Polymarket beat probability of 95% means a beat is largely already priced in; post-print move depends on magnitude vs whisper numbers and AI revenue guidance
• Anthropic counterparty concentration adds credit risk that rating agencies won't treat like pure-play chip vendor
• Polymarket pricing 89% probability of no Fed cuts in 2026; stable rates environment supportive for high-duration growth names
• 30-quarter beat streak is deliberate management behavior (low-balling guidance), not survivorship bias; streak itself is information
• Forward P/E of 18.9 and PEG of 0.4 is genuinely unusual and analytically useful despite high trailing P/E of 61x
• Beta of 1.47 means position moves roughly 50% more than S&P; firm should assess total tech/AI-complex exposure across portfolio
• August drawdown of 25% in two months is direct evidence AVGO can fall sharply; coiled springs fire in both directions
• AI financing deal structure: $70 to $80 billion in AI financing creates structural leverage change being hand-waved by aggressive camp
• Conservative 'don't add until catalyst resolves' forfeits re-rating window; buying back at 386 means missing 4-5% upside
• Upside resistance levels: 20 SMA at 391, then 420 to 428; downside stop at 354; lower Bollinger band near 338

→ vs aggressive: The 'coiled spring' interpretation of ATR compression is narrative bias; ATR signals volatility is coming in either direction, not bullish continuation

→ vs aggressive: Debt deal framing as 'strategic moat extension' ignores the pro-forma net debt to EBITDA move from 1.07x to 3.0-3.1x; belief in management is not analysis

→ vs aggressive: Mizuho's call on violent upside is a hypothesis, not data; treating it as fact is the same error as the coiled spring thesis

→ vs aggressive: 200 SMA defended by 26 cents is fragile, not strong; beta of 1.47 means single bad session can crack level

→ vs conservative: Thirty-quarter beat streak dismissal as 'survivorship bias' is too clean; it's deliberate management behavior and is information

→ vs conservative: Trailing P/E at 61x framing ignores forward P/E of 18.9 and PEG of 0.4, the most analytically useful signal; dismissing PEG is avoidance, not risk management

→ vs conservative: 'Downside not capped at 354' argument cuts both ways; upside isn't capped at 386 either; treating one side as unbounded while the other is bounded is a one-sided risk model

→ vs conservative: 'Don't add until catalyst resolves' has real cost; if AVGO beats and reclaims 386, waiting for confirmation means buying 4-5% higher; patience costs nothing until it costs everything